MERLINVET-CEL LTD

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  -0.4%

  £47,989,681 → £47,774,902

• Cash

  -74.7%

  £2,495,134 → £630,868

• Net assets

  -17.8%

  £2,100,780 → £1,726,155

• Employees

  -20%

  15 → 12

• Operating profit

  -78%

  £558,303 → £122,977

• Profit before tax

  -72%

  £592,263 → £165,626

• Wages

  +34.8%

  £400,885 → £540,472

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. MERLINVET-CEL LTD 2022-05-09 → present
2. VETCEL LIMITED 1984-07-31 → 2022-05-09
3. L A BUSINESS RADIO LIMITED 1983-10-13 → 1984-07-31

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

Clive Owen LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.”

Group structure

1. MERLINVET-CEL LTD · parent
   1. Vetcel Ltd 100% · Scotland · dormant company
   2. Merlin Salus Pam Ltd 100% · Scotland · provision of PAM (Personal Anaesthetic Monitoring) badges to veterinary practices

Significant events

• “After a fourth consecutive year of adverse trading conditions caused by the pandemic, we do continue to hold our own. The continuing acquisition of UK veterinary practices and the corporatisation of the wider veterinary industry remains a challenge. Further investigations by the Competition & Markets Authority into animal medicines pricing in the UK continue to be a challenge for the company.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

3

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.